| __timestamp | Arrowhead Pharmaceuticals, Inc. | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 175000 | 125519000 |
| Thursday, January 1, 2015 | 382000 | 135522000 |
| Friday, January 1, 2016 | 158333 | 137780000 |
| Sunday, January 1, 2017 | 31407709 | 162135000 |
| Monday, January 1, 2018 | 16142321 | 174885000 |
| Tuesday, January 1, 2019 | 168795577 | 174811000 |
| Wednesday, January 1, 2020 | 87992066 | 138761000 |
| Friday, January 1, 2021 | 138287000 | 187695000 |
| Saturday, January 1, 2022 | 232810000 | 581703000 |
| Sunday, January 1, 2023 | 240735000 | 709543000 |
| Monday, January 1, 2024 | 3551000 |
Igniting the spark of knowledge
In the ever-evolving landscape of biotechnology and pharmaceuticals, Lantheus Holdings, Inc. and Arrowhead Pharmaceuticals, Inc. have emerged as key players. Over the past decade, Lantheus has consistently demonstrated robust growth, with its gross profit soaring by over 460% from 2014 to 2023. This impressive trajectory underscores its strategic prowess in the medical imaging sector.
Conversely, Arrowhead Pharmaceuticals, known for its pioneering RNA interference therapies, has shown a remarkable 137,000% increase in gross profit from 2014 to 2023. This growth highlights its successful transition from a nascent biotech firm to a formidable force in genetic medicine.
While Lantheus's financial journey reflects steady expansion, Arrowhead's meteoric rise is a testament to its innovative breakthroughs. As we look to the future, these companies exemplify the dynamic potential of the biotech industry, each carving its unique path to success.
Eli Lilly and Company and Lantheus Holdings, Inc.: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Pfizer Inc. and Lantheus Holdings, Inc.
Bristol-Myers Squibb Company and Lantheus Holdings, Inc.: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.
Dr. Reddy's Laboratories Limited and Arrowhead Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: Catalent, Inc. vs Lantheus Holdings, Inc.
Lantheus Holdings, Inc. and Corcept Therapeutics Incorporated: A Detailed Gross Profit Analysis
Annual Revenue Comparison: Lantheus Holdings, Inc. vs Arrowhead Pharmaceuticals, Inc.
Key Insights on Gross Profit: Lantheus Holdings, Inc. vs Perrigo Company plc
Key Insights on Gross Profit: Lantheus Holdings, Inc. vs Vericel Corporation
Key Insights on Gross Profit: Alkermes plc vs Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis